Increasing the proliferative capacity of cells using telomerase reverse transcriptase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 8, 2009
Grant Date -
N/A
app pub date -
Nov 2, 1999
filing date -
Oct 1, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully